In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Windtree Therapeutics, Inc.

http://www.windtreetx.com/

Latest From Windtree Therapeutics, Inc.

Lessons Learned And What's Ahead: I-Mab, JW, RemeGen CEOs On Biotech Financing

Top executives from three high-flying biotechs, all have gone public on Nasdaq and Hong Kong Stock Exchange, offering lessons learned and looking forward to what’s ahead for Chinese biotech.

Financing China

Medicare’s Antibiotic Boost: Six Qualify For Add-On Payment

CMS final rule for hospital payment in 2021 includes enhanced payment for six novel antibiotics – including one that is not yet approved by FDA. New policies to encourage antibiotic innovation are clearly having an impact in the context of Medicare payments.

Medicare Infectious Diseases

Antibiotic Action Fund Remains Stop-Gap As Industry Waits For Reimbursement Legislation

Pharma-backed investment fund to combat antimicrobial resistance aims to find Phase II-ready programs, but can’t generate a constant flow of innovation without better ‘pull’ incentives, industry says.

Infectious Diseases Reimbursement

AMR Action Fund Will Start Screening Antibiotic Candidates Early Next Year

The industry-backed investment fund to combat antimicrobial resistance hopes to be operational by end of year and begin assessing programs to invest in during the first quarter of 2021.

Policy Financing
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
  • Biotechnology
    • Large Molecule
    • Drug Discovery Tools
      • ADMET
  • Other Names / Subsidiaries
    • Discovery Labs
UsernamePublicRestriction

Register